US 10335402
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated gastrointestinal disorders
granted A61KA61K31/454A61P
Quick answer
US patent 10335402 (Sulfonyl piperidine derivatives and their use for treating prokineticin mediated gastrointestinal disorders) held by Takeda Pharmaceutical Company Limited expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/454, A61P, A61P1/00, A61P1/12